A new study by University of Virginia Health System researchers has
found that prostate cancer patients who reach a very low-level PSA
(prostate-specific antigen) after combined radiation treatment using
brachytherapy "seeds" and hormone therapy have a 99 percent chance of
survival free from disease. In this study, PSA level was measured by a
blood test six to 12 months after therapy.
"This finding is significant because the indicator point, PSA less than
or equal to 0.06 ng/mL (nanograms per milliliter), is a tool that early
on can reassure a patient that chances of survival are excellent.
Previously, men had to wait six or seven years for such news," said Dr.
Dan Theodorescu, professor of urology and director of the Mellon
Prostate Cancer Institute at UVa. "It is a good indicator that the
person will continue without further disease." The study is available
online in advance of print in the journal Cancer, the official journal
of the American Cancer Society.
Importantly, this finding also is useful for patients who don't reach
such a low level of PSA after treatment. "If patients don't reach the
0.06 ng/mL level, they should be monitored and closely followed up, as
their chances of cancer recurrence are higher," Dr. Theodorescu
explains. "However, these patients overall did fairly well, with an 85
percent chance of disease-free survival over the study period, which
included patientstreated from March 1997 to November 2002."
In 2004, 29,900 deaths from prostate cancer were estimated to occur in
the United States alone, making it the second leading cause of cancer
death in men. All men are at risk for prostate cancer, and risk
increases with age and family history of the cancer.
UVa Department of Urology is ranked as one of the nation's top
departments in this medical specialty by U.S. News & World Report.
Patients in this study were jointly treated by physicians in the
Departments of Urology and Radiation Oncology at UVa Health System.
knowledge is power - growing old is mandatory - growing wise is optional
"Many more men die with prostate cancer than of it. Growing old is
invariably fatal. Prostate cancer is only sometimes so."
http://community.webtv.net/PALMER_ENT/doc
rweigle@sbcglobal.net - 18 Jun 2005 05:01 GMT
I got cut off early from the initial posting question regarding this
article. Can you provide the specific url or location address for this
article?
Thanks,
Richard fr Monterey
Steve Kramer - 18 Jun 2005 17:50 GMT
For rweigle

Signature
PSA 16 10/17/2000 @ 46
Biopsy 11/01/2000 G7 (3+4), T2c
RRP 12/15/2000 G7 (3+4), T3cN0M0 Neg margins
PSA .1 .1 .1 .27 .37 .75
EBRT 05-07/2002 @ 47
PSA .34 .22 .15 .21 .32
Lupron 07/03 (1 mo) 8/03 (4 mo), 12/03, 4/04, 09/04, 01/05
PSA .07 .05 .06 .05
non Illegitimi carborundum
> A new study by University of Virginia Health System researchers has
> found that prostate cancer patients who reach a very low-level PSA
[quoted text clipped - 35 lines]
> invariably fatal. Prostate cancer is only sometimes so."
> http://community.webtv.net/PALMER_ENT/doc